pISSN 1226-6051
eISSN 2508-786X

Table. 4.

Table. 4.

List of selected research topics based on the preference score and consultation with the clinical experts

Study populationTarget vaccine(s)Adverse event(s)Study design
12-year-old female teenagersHPV-2 and HPV-4 (Cervarix, Gardasil)Autoimmune diseases, neurological disorders, VTE etc.Cohort study/SCRI
General populationInfluenza vaccineAll adverse eventsSignal detection/ case-noncase study
General populationAll NIP vaccinesAnaphylaxisIncidence rate study
General populationQuadrivalent influenza vaccine and trivalent influenza vaccineHospitalization, lower respiratory tract infection, hypersensitivity, seizure, wheezing, encephalomeningitis, facial nerve paralysis etc.Cohort study/SCRI
General populationPPSV, PCVAll adverse eventsCohort study/SCRI

HPV, human papillomavirus; VTE, venous thromboembolism; KAERS, Korea Adverse Event Reporting System; VAERS, Vaccine Adverse Event Reporting System; NIP; National Immunization Program; PPSV, pneumococcal polysaccharide vaccine; PCV, pneumococcal conjugate vaccine; SCRI, Self-Controlled Risk-Interval

Korean J Clin Pharm 2019;29:173-85 https://doi.org/10.24304/kjcp.2019.29.3.173
© 2019 Korean J Clin Pharm